Nasal Cannula Market Report 2026

Nasal Cannula Market Overview

• Nasal Cannula market size has reached to $9.79 billion in 2025 • Expected to grow to $15.31 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Respiratory Diseases Fuel Growth In The Market • Market Trend: Technological Advancements In Low-Flow Nasal Cannulas For Enhanced Patient Comfort And Oxygen Delivery Efficiency • North America was the largest region in 2025.

What Is Covered Under Nasal Cannula Market?

A nasal cannula is a medical device used to deliver supplemental oxygen to patients who require respiratory support. It consists of two small prongs that fit into the nostrils, connected by a thin tube to an oxygen source. This device allows for comfortable, continuous oxygen flow while enabling the patient to speak and eat. The main types of nasal cannula are low-flow nasal cannula and high-flow nasal cannula. A low-flow nasal cannula is a medical device that delivers a small amount of oxygen through two prongs placed in the nostrils to help patients with respiratory difficulties breathe more easily. It is made from materials such as plastic and silicone and is available in various sizes, including neonate, infant, child, and adult. It is also available in different prong designs, with options such as straight, curved, flared, and other variations is used by several end users, including hospitals, ambulatory healthcare services, long-term care centers, and other healthcare settings.

What Is The Nasal Cannula Market Growth Forecast?

The nasal cannula market size is expected to see strong growth in the next few years. It will grow to $15.31 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for home oxygen therapy, growth in high-flow nasal cannula adoption, rising investments in respiratory care innovation, expanding use in long-term care facilities, development of advanced ergonomic cannula designs. Major trends in the forecast period include increasing adoption of high-flow nasal cannula therapy, rising demand for disposable oxygen delivery devices, growing use of nasal cannulas in home healthcare settings, expanding pediatric and neonatal respiratory support solutions, advancements in soft, skin-friendly cannula materials.

What Is The Driver Of The Nasal Cannula Market?

The increasing number of respiratory diseases is significantly contributing to the growth of the nasal cannula market. Respiratory diseases are medical conditions that affect the lungs and airways, impairing breathing and oxygen exchange. Rises in respiratory diseases can be attributed to factors such as air pollution, smoking, viral infections, and increased exposure to allergens. A nasal cannula is used in respiratory diseases to deliver supplemental oxygen directly into the nostrils, improving oxygen levels in patients with breathing difficulties. For instance, in June 2025, according to the Office for Health Improvement and Disparities (OHID), a UK-based government department, the rate of emergency admissions for respiratory disease in England increased by 7% from the financial year ending 2023 to the financial year ending 2024. Therefore, the increasing number of respiratory diseases drives the growth of the nasal cannula industry.

Key Players In The Global Nasal Cannula Market

Major companies operating in the nasal cannula market are Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., HUM GmbH

Global Nasal Cannula Market Trends and Insights

Major companies operating in the nasal cannula market are focusing on technological innovations, such as low-flow nasal cannulas, to enhance patient comfort, improve oxygen delivery efficiency, and meet specific clinical requirements. A low-flow nasal cannula is a device designed to deliver supplemental oxygen at lower flow rates, usually ranging from 1 to 6 liters per minute, through two prongs inserted into the nostrils. For instance, in May 2024, CNSAC MedShop, a Germany-based diagnostics and consumables company, introduced NasalOxy, a revolutionary, patented low-flow nasal cannula designed to address the limitations of traditional oxygen delivery methods. This innovative device provides unparalleled comfort and effectiveness for patients requiring long-term oxygen therapy while also offering versatility for supporting both nasal and oral breathing. The advanced design of NasalOxy reduces contact with the mucous membrane, thereby minimizing irritation and discomfort and eliminating common side effects associated with traditional nasal cannulas.

What Are Latest Mergers And Acquisitions In The Nasal Cannula Market?

In May 2023, Flexicare, a UK-based provider of respiratory care devices and airway management solutions, acquired Clement Clarke International for an undisclosed amount. With this acquisition, Flexicare aims to expand its respiratory care portfolio, strengthen its diagnostic and monitoring capabilities, and enhance its global position in the management and treatment of respiratory conditions. Clement Clarke International is a UK-based provider of respiratory diagnostic devices, inhaler training tools, and peak flow meters used for monitoring and supporting patients with asthma and other respiratory disorders.

What Defines the Nasal Cannula Market?

The nasal cannula market consists of sales of standard nasal cannulas, pediatric nasal cannulas, disposable nasal cannulas, and reusable nasal cannulas. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nasal Cannula Market Report 2026?

The nasal cannula market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nasal cannula industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.